• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Broadlane cuts deals with R2 and Varian

Article

Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The

Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The exclusive agreement with R2, which extends to Dec. 31, 2004, provides access for Broadlane customers to R2's ImageChecker CAD mammography system. Varian will offer Broadlane institutions a range of radiotherapy products including its Clinac medical linear accelerators, Millennium multileaf collimators, and PortalVision electronic portal imaging systems. Broadlane customers will also have access to imaging products from GE Medical Systems that Varian distributes in North America under a special See and Treat Cancer Care partnership agreement.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.